Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Biochemical Reagents Market by Product Type (Polymerase Chain Reaction Reagent Kits, Cell and Tissue Culture Reagents, Electrophoresis Reagents, Chromatography Reagents, Others) and by End User (Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations, Contract Development and Manufacturing Organization, Research Institutes, Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2023-2032

A12339

Pages: NA

Charts: NA

Tables: NA

Biochemical Reagents Market Overview 2030:

Biochemical reagent is a chemical found in a biological system or a chemical that can be used in biological research. These reagents include molecules such as vitamins, amino acids, and nucleotides, which are known to be essential for life. Biochemical reagents further include inorganic and organic chemicals that find their applications in life science. Therefore, these reagents could be detergents, salts, and other small molecules that can impart biological effects or are essential for biological assays. A diverse range of biochemical reagents is used for differentiating between bacteria and in the identification of certain types of metabolisms.

COVID-19 Impact Analysis

COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the biotechnology industry is expected to witness significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the biochemical reagents market as these reagents find applications in culture preparation and during research in the field of biotechnology.

Top Impacting Factors

Rise in focus of key players on research and development in the field of biochemical reagents is acting as a major driver for the biochemical reagents market. These key players are focused on widening the applications of biochemical reagents in the healthcare and life science sectors.

Many biochemical reagents are used in the imaging and diagnosis of chronic diseases. Hence, surge in cases of chronic diseases is a key factor contributing to the growth of the biochemical reagents market.

In addition, biochemical reagents are used in the biotechnology sector in advanced analytical technologies, which include next-generation gene sequencing and polymerase chain sequencing. Advancements in these technologies over the years have helped boost the market.

However, implementation of stringent government regulations against the approval of newly developed biochemical reagents impedes the growth of the biochemical reagents market.

Key Market Trends

The chromatography segment of the biochemical reagents market captures the largest market share, owing to its wide applications such as in the separation of biomolecules and chemical molecules, protein purification, and diagnostics.

Key players in the biochemical reagents market are partnering with other players to expand their presence in different regions and enhance their product portfolio of biochemical reagents. In addition, governments of many developed nations are funding the research and development activities of biochemical reagents.

North America dominates the biochemical reagents market with the U.S. being the major contributor. The presence of many biopharmaceutical companies coupled with the nation’s increased investment in the biotechnology and healthcare sector has led to this growth.

The Asia-Pacific market for biochemical reagents is anticipated to grow during the forecast period, owing to the developing healthcare and diagnostics infrastructure and increasing number of biotechnology and biopharmaceutical companies.

Key Benefits of the Report

  • This study presents the analytical depiction of the biochemical reagents industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the market share.
  • The current market is quantitatively analyzed to highlight the growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Biochemical Reagents Report

  • Which are the leading players active in the biochemical reagents market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the biochemical reagents market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What are the impacts of COVID-19 in the industry?
  • What are biochemical reagents?
  • What are the current trends and predicted trends?

 Key Market Segments

  • By Product Type
    • Polymerase Chain Reaction Reagent Kits
    • Cell and Tissue Culture Reagents
    • Electrophoresis Reagents
    • Chromatography Reagents
    • Others
  • By End User
    • Biotechnology Companies
    • Pharmaceutical Companies
    • Contract Research Organizations
    • Contract Development and Manufacturing Organization
    • Research Institutes
    • Academic Institutes
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Thermo Fisher Scientific Inc.
  • Johnson and Johnson
  • Beckton Dickinson and Company
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • Waters Corporation
  • Siemens Healthineers
  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Agilent Technologies Inc.

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: BIOCHEMICAL REAGENTS MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Polymerase Chain Reaction Reagent Kits

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Cell And Tissue Culture Reagents

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Electrophoresis Reagents

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Chromatography Reagents

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Others

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

  • CHAPTER 5: BIOCHEMICAL REAGENTS MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Biotechnology Companies

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Pharmaceutical Companies

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Contract Research Organizations

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Contract Development And Manufacturing Organization

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Research Institutes

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Academic Institutes

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

  • CHAPTER 6: BIOCHEMICAL REAGENTS MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product Type

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Biochemical Reagents Market

        • 6.2.5.1. Market Size and Forecast, By Product Type
        • 6.2.5.2. Market Size and Forecast, By End User

      • 6.2.6. Canada Biochemical Reagents Market

        • 6.2.6.1. Market Size and Forecast, By Product Type
        • 6.2.6.2. Market Size and Forecast, By End User

      • 6.2.7. Mexico Biochemical Reagents Market

        • 6.2.7.1. Market Size and Forecast, By Product Type
        • 6.2.7.2. Market Size and Forecast, By End User

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product Type

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Biochemical Reagents Market

        • 6.3.5.1. Market Size and Forecast, By Product Type
        • 6.3.5.2. Market Size and Forecast, By End User

      • 6.3.6. Germany Biochemical Reagents Market

        • 6.3.6.1. Market Size and Forecast, By Product Type
        • 6.3.6.2. Market Size and Forecast, By End User

      • 6.3.7. Italy Biochemical Reagents Market

        • 6.3.7.1. Market Size and Forecast, By Product Type
        • 6.3.7.2. Market Size and Forecast, By End User

      • 6.3.8. Spain Biochemical Reagents Market

        • 6.3.8.1. Market Size and Forecast, By Product Type
        • 6.3.8.2. Market Size and Forecast, By End User

      • 6.3.9. UK Biochemical Reagents Market

        • 6.3.9.1. Market Size and Forecast, By Product Type
        • 6.3.9.2. Market Size and Forecast, By End User

      • 6.3.10. Russia Biochemical Reagents Market

        • 6.3.10.1. Market Size and Forecast, By Product Type
        • 6.3.10.2. Market Size and Forecast, By End User

      • 6.3.11. Rest Of Europe Biochemical Reagents Market

        • 6.3.11.1. Market Size and Forecast, By Product Type
        • 6.3.11.2. Market Size and Forecast, By End User

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product Type

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Biochemical Reagents Market

        • 6.4.5.1. Market Size and Forecast, By Product Type
        • 6.4.5.2. Market Size and Forecast, By End User

      • 6.4.6. Japan Biochemical Reagents Market

        • 6.4.6.1. Market Size and Forecast, By Product Type
        • 6.4.6.2. Market Size and Forecast, By End User

      • 6.4.7. India Biochemical Reagents Market

        • 6.4.7.1. Market Size and Forecast, By Product Type
        • 6.4.7.2. Market Size and Forecast, By End User

      • 6.4.8. South Korea Biochemical Reagents Market

        • 6.4.8.1. Market Size and Forecast, By Product Type
        • 6.4.8.2. Market Size and Forecast, By End User

      • 6.4.9. Australia Biochemical Reagents Market

        • 6.4.9.1. Market Size and Forecast, By Product Type
        • 6.4.9.2. Market Size and Forecast, By End User

      • 6.4.10. Thailand Biochemical Reagents Market

        • 6.4.10.1. Market Size and Forecast, By Product Type
        • 6.4.10.2. Market Size and Forecast, By End User

      • 6.4.11. Malaysia Biochemical Reagents Market

        • 6.4.11.1. Market Size and Forecast, By Product Type
        • 6.4.11.2. Market Size and Forecast, By End User

      • 6.4.12. Indonesia Biochemical Reagents Market

        • 6.4.12.1. Market Size and Forecast, By Product Type
        • 6.4.12.2. Market Size and Forecast, By End User

      • 6.4.13. Rest of Asia Pacific Biochemical Reagents Market

        • 6.4.13.1. Market Size and Forecast, By Product Type
        • 6.4.13.2. Market Size and Forecast, By End User

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product Type

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Biochemical Reagents Market

        • 6.5.5.1. Market Size and Forecast, By Product Type
        • 6.5.5.2. Market Size and Forecast, By End User

      • 6.5.6. South Africa Biochemical Reagents Market

        • 6.5.6.1. Market Size and Forecast, By Product Type
        • 6.5.6.2. Market Size and Forecast, By End User

      • 6.5.7. Saudi Arabia Biochemical Reagents Market

        • 6.5.7.1. Market Size and Forecast, By Product Type
        • 6.5.7.2. Market Size and Forecast, By End User

      • 6.5.8. UAE Biochemical Reagents Market

        • 6.5.8.1. Market Size and Forecast, By Product Type
        • 6.5.8.2. Market Size and Forecast, By End User

      • 6.5.9. Argentina Biochemical Reagents Market

        • 6.5.9.1. Market Size and Forecast, By Product Type
        • 6.5.9.2. Market Size and Forecast, By End User

      • 6.5.10. Rest of LAMEA Biochemical Reagents Market

        • 6.5.10.1. Market Size and Forecast, By Product Type
        • 6.5.10.2. Market Size and Forecast, By End User

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Thermo Fisher Scientific Inc.

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Abbott Laboratories

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Agilent Technologies Inc.

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Beckton Dickinson And Company

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Bio-Rad Laboratories

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Merck KGaA

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Waters Corporation

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Siemens Healthineers

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. F. Hoffmann-La Roche Ltd

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Johnson And Johnson

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL BIOCHEMICAL REAGENTS MARKET, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL BIOCHEMICAL REAGENTS MARKET FOR POLYMERASE CHAIN REACTION REAGENT KITS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL BIOCHEMICAL REAGENTS MARKET FOR CELL AND TISSUE CULTURE REAGENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL BIOCHEMICAL REAGENTS MARKET FOR ELECTROPHORESIS REAGENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL BIOCHEMICAL REAGENTS MARKET FOR CHROMATOGRAPHY REAGENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL BIOCHEMICAL REAGENTS MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL BIOCHEMICAL REAGENTS MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL BIOCHEMICAL REAGENTS MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL BIOCHEMICAL REAGENTS MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL BIOCHEMICAL REAGENTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL BIOCHEMICAL REAGENTS MARKET FOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL BIOCHEMICAL REAGENTS MARKET FOR RESEARCH INSTITUTES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL BIOCHEMICAL REAGENTS MARKET FOR ACADEMIC INSTITUTES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL BIOCHEMICAL REAGENTS MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. NORTH AMERICA BIOCHEMICAL REAGENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 18. U.S. BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 19. U.S. BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 20. CANADA BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 21. CANADA BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 22. MEXICO BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 23. MEXICO BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 24. EUROPE BIOCHEMICAL REAGENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 25. EUROPE BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 26. EUROPE BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 27. FRANCE BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 28. FRANCE BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 29. GERMANY BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 30. GERMANY BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 31. ITALY BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 32. ITALY BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 33. SPAIN BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 34. SPAIN BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 35. UK BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 36. UK BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 37. RUSSIA BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 38. RUSSIA BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 39. REST OF EUROPE BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 40. REST OF EUROPE BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 41. ASIA-PACIFIC BIOCHEMICAL REAGENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 42. ASIA-PACIFIC BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 43. ASIA-PACIFIC BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 44. CHINA BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 45. CHINA BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 46. JAPAN BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 47. JAPAN BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 48. INDIA BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 49. INDIA BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 50. SOUTH KOREA BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 51. SOUTH KOREA BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 52. AUSTRALIA BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 53. AUSTRALIA BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 54. THAILAND BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 55. THAILAND BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 56. MALAYSIA BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 57. MALAYSIA BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 58. INDONESIA BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 59. INDONESIA BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 60. REST OF ASIA PACIFIC BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 61. REST OF ASIA PACIFIC BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 62. LAMEA BIOCHEMICAL REAGENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 63. LAMEA BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 64. LAMEA BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 65. BRAZIL BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 66. BRAZIL BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 67. SOUTH AFRICA BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 68. SOUTH AFRICA BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 69. SAUDI ARABIA BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 70. SAUDI ARABIA BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 71. UAE BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 72. UAE BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 73. ARGENTINA BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 74. ARGENTINA BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 75. REST OF LAMEA BIOCHEMICAL REAGENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 76. REST OF LAMEA BIOCHEMICAL REAGENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 77. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
  • TABLE 78. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 79. THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
  • TABLE 80. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
  • TABLE 81. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 82. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 83. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 84. ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 85. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 86. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 87. AGILENT TECHNOLOGIES INC.: KEY EXECUTIVES
  • TABLE 88. AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT
  • TABLE 89. AGILENT TECHNOLOGIES INC.: OPERATING SEGMENTS
  • TABLE 90. AGILENT TECHNOLOGIES INC.: PRODUCT PORTFOLIO
  • TABLE 91. AGILENT TECHNOLOGIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 92. BECKTON DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 93. BECKTON DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 94. BECKTON DICKINSON AND COMPANY: OPERATING SEGMENTS
  • TABLE 95. BECKTON DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 96. BECKTON DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 97. BIO-RAD LABORATORIES: KEY EXECUTIVES
  • TABLE 98. BIO-RAD LABORATORIES: COMPANY SNAPSHOT
  • TABLE 99. BIO-RAD LABORATORIES: OPERATING SEGMENTS
  • TABLE 100. BIO-RAD LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 101. BIO-RAD LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 102. MERCK KGAA: KEY EXECUTIVES
  • TABLE 103. MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 104. MERCK KGAA: OPERATING SEGMENTS
  • TABLE 105. MERCK KGAA: PRODUCT PORTFOLIO
  • TABLE 106. MERCK KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 107. WATERS CORPORATION: KEY EXECUTIVES
  • TABLE 108. WATERS CORPORATION: COMPANY SNAPSHOT
  • TABLE 109. WATERS CORPORATION: OPERATING SEGMENTS
  • TABLE 110. WATERS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 111. WATERS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. SIEMENS HEALTHINEERS: KEY EXECUTIVES
  • TABLE 113. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
  • TABLE 114. SIEMENS HEALTHINEERS: OPERATING SEGMENTS
  • TABLE 115. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
  • TABLE 116. SIEMENS HEALTHINEERS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. F. HOFFMANN-LA ROCHE LTD: KEY EXECUTIVES
  • TABLE 118. F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT
  • TABLE 119. F. HOFFMANN-LA ROCHE LTD: OPERATING SEGMENTS
  • TABLE 120. F. HOFFMANN-LA ROCHE LTD: PRODUCT PORTFOLIO
  • TABLE 121. F. HOFFMANN-LA ROCHE LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 122. JOHNSON AND JOHNSON: KEY EXECUTIVES
  • TABLE 123. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
  • TABLE 124. JOHNSON AND JOHNSON: OPERATING SEGMENTS
  • TABLE 125. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
  • TABLE 126. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOCHEMICAL REAGENTS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL BIOCHEMICAL REAGENTS MARKET
  • FIGURE 3. SEGMENTATION BIOCHEMICAL REAGENTS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN BIOCHEMICAL REAGENTS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALBIOCHEMICAL REAGENTS MARKET
  • FIGURE 11. BIOCHEMICAL REAGENTS MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. BIOCHEMICAL REAGENTS MARKET FOR POLYMERASE CHAIN REACTION REAGENT KITS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. BIOCHEMICAL REAGENTS MARKET FOR CELL AND TISSUE CULTURE REAGENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. BIOCHEMICAL REAGENTS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. BIOCHEMICAL REAGENTS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. BIOCHEMICAL REAGENTS MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. BIOCHEMICAL REAGENTS MARKET SEGMENTATION, BY BY END USER
  • FIGURE 18. BIOCHEMICAL REAGENTS MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. BIOCHEMICAL REAGENTS MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. BIOCHEMICAL REAGENTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. BIOCHEMICAL REAGENTS MARKET FOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. BIOCHEMICAL REAGENTS MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. BIOCHEMICAL REAGENTS MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 25. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 26. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 27. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 28. COMPETITIVE DASHBOARD
  • FIGURE 29. COMPETITIVE HEATMAP: BIOCHEMICAL REAGENTS MARKET
  • FIGURE 30. TOP PLAYER POSITIONING, 2024
  • FIGURE 31. THERMO FISHER SCIENTIFIC INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 32. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 33. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 34. ABBOTT LABORATORIES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 35. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 36. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 37. AGILENT TECHNOLOGIES INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. AGILENT TECHNOLOGIES INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. AGILENT TECHNOLOGIES INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. BECKTON DICKINSON AND COMPANY: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. BECKTON DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. BECKTON DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. BIO-RAD LABORATORIES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. BIO-RAD LABORATORIES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. BIO-RAD LABORATORIES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. MERCK KGAA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. MERCK KGAA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. MERCK KGAA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. WATERS CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. WATERS CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. WATERS CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. SIEMENS HEALTHINEERS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. SIEMENS HEALTHINEERS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. SIEMENS HEALTHINEERS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 55. F. HOFFMANN-LA ROCHE LTD: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 56. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 57. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 58. JOHNSON AND JOHNSON: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 59. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 60. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Biochemical Reagents Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved